ALT Competitors & Alternatives
Compare Altimmune Inc with similar stocks in the same industry
Biotechnology
ALT
Main Stock$2.99
Tradestie Score
62
Market Cap
$341.56M
Revenue Growth
4.2%
Analyst Upside
+416.7%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARVN
Arvinas, Inc
|
$8.10
|
$670.30M | - | 48 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$12.34
|
$665.30M | - | 59 | Compare |
|
ANL
ANL
|
$9.24
|
$635.61M | - | 49 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$17.90
|
$626.91M | - | 59 | Compare |
|
SVRA
Savara Inc.
|
$5.74
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.70
|
$552.46M | - | 59 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$14.71
|
$540.97M | - | 62 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.18
|
$529.35M | 6.6 | 48 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$103.33
|
$522.78M | - | 54 | Compare |
More ALT Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry